Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marcia Belvin currently holds 300,760 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marcia Belvin has been a net seller of CTMX stock. They have purchased $0 and sold $245.1K worth of shares.
Marcia Belvin's most recent insider trade was on Mar 17, 2026, when they sold 31,492 shares at $6.42 per share.
Marcia Belvin serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 15 insider transactions totaling $245.1K over their tenure at the company.
Marcia Belvin holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Marcia Belvin has shown a selling trading pattern, with $0 in total purchases and $245.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Marcia Belvin was on Mar 17, 2026, when they sold $202.3K worth of CTMX shares. This transaction involved 31,492 shares at $6.42 per share.
Marcia Belvin currently owns 300,760 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marcia Belvin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marcia Belvin has 15 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for Marcia Belvin and 40,000+ other insiders.